BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]
Dr. Rowena Ridout is the new chair of Osteoporosis Canada’s Scientific Advisory Council. Rowena has been involved with Osteoporosis Canada since 2010 as an active member of the Scientific Advisory Council. […]
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
